Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

deCODE Genetics, Sturlugata 8, Reykjavik, Iceland.
Nature Genetics (Impact Factor: 35.21). 03/2009; 41(4):460-4. DOI:10.1038/ng.339
Source: PubMed

ABSTRACT In order to search for sequence variants conferring risk of thyroid cancer we conducted a genome-wide association study in 192 and 37,196 Icelandic cases and controls, respectively, followed by a replication study in individuals of European descent. Here we show that two common variants, located on 9q22.33 and 14q13.3, are associated with the disease. Overall, the strongest association signals were observed for rs965513 on 9q22.33 (OR = 1.75; P = 1.7 x 10(-27)) and rs944289 on 14q13.3 (OR = 1.37; P = 2.0 x 10(-9)). The gene nearest to the 9q22.33 locus is FOXE1 (TTF2) and NKX2-1 (TTF1) is among the genes located at the 14q13.3 locus. Both variants contribute to an increased risk of both papillary and follicular thyroid cancer. Approximately 3.7% of individuals are homozygous for both variants, and their estimated risk of thyroid cancer is 5.7-fold greater than that of noncarriers. In a study on a large sample set from the general population, both risk alleles are associated with low concentrations of thyroid stimulating hormone (TSH), and the 9q22.33 allele is associated with low concentration of thyroxin (T(4)) and high concentration of triiodothyronine (T(3)).

0 0
  • [show abstract] [hide abstract]
    ABSTRACT: Forkhead box E1 encodes the transcription factor FOXE1 (or TTF-2), which together with Homeobox protein NKX2-1, PAX8 and HHEX, are pivotal proteins required for thyroid gland formation, differentiation and function. Recently, genome-wide association studies have identified FOXE1 as a thyroid cancer (TC) susceptibility gene in populations of European descent. After that, a number of studies reported that the rs965513, rs1867277, and rs71369530 polymorphism in FOXE1 has been implicated in TC risk. However, the causal variants remain unknown. To derive a more precise estimation of the relationship, a meta-analysis of 9,828 TC cases and 109,995 controls from 14 case-control studies was performed. Overall, significant results were observed for rs965513 (OR = 1.71, 95% CI: 1.59-1.85, P<10(-5)), rs1867277 (OR = 1.64, 95% CI: 1.51-1.78, P<10(-5)) and rs71369530 (OR = 2.01, 95% CI: 1.66-2.44, P<10(-5)) polymorphism. In the subgroup analysis by ethnicity, we found that rs965513 polymorphism confer high risk for Caucasians with per-allele OR of 1.80 (95% CI: 1.69-1.92, P<10(-5)) compared to East Asians of 1.35 (95% CI: 1.09-1.67, P = 0.006). There was strong evidence of heterogeneity, which largely disappeared after stratification by ethnicity. In the subgroup analysis by sample size, and study design, significantly increased risks were found for the polymorphism. In conclusion, this meta-analysis demonstrated that common variations of FOXE1 are a risk factor associated with increased TC susceptibility.
    PLoS ONE 01/2014; 9(1):e87332. · 3.73 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: MicroRNAs (miRNAs) have emerged as a class of powerful gene expression regulators. Acting at the post-transcriptional level, miRNAs modulate the expression of at least one-third of the mRNAs that are encoded by the human genome. The expression of a single gene can be regulated by several miRNAs, and every miRNA has more than one target gene. Thus, the miRNA regulatory circuit, which affects essential cellular functions, is of enormous complexity. Moreover, a fundamental role for miRNAs has been determined in the onset and progression of human cancers. Here, we summarize the main alterations in miRNA expression that have been identified in thyroid neoplasias and examine the mechanisms through which miRNA deregulation might promote thyroid cell transformation. We also discuss how the emerging knowledge on miRNA deregulation could be harnessed for the diagnosis and treatment of thyroid neoplasias.
    Nature Reviews Endocrinology 11/2013; · 11.03 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: The international team of authors of the present book attempts to sum up and overview the enormous and unique materials obtained from studies of Ukrainian thyroid cancer that have been accumulated over the years after the Chernobyl accident. Comprehensive scientific analysis is now expected to be useful for the future studies of radiation-associated thyroid cancers.
    1st edited by M Tronko, T Bogdanova, V Saenko, I Likhtarov, GA Thomas, S Yamashita, 02/2014; Nagasaki Association of Hibakushas' Medical Care (NASHIM)., ISBN: 4-931481-08-6

Full-text (2 Sources)

Available from
Nov 4, 2013